[Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-02-18 Disclosures
[Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-02-18 Disclosures
[Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18 Disclosures
[Disclosure] Hanwha Ocean (042660) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-02-18 Disclosures
[Disclosure] Hanwha Ocean (042660) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-02-18 Disclosures
[Disclosure] Hanwha Ocean (042660) – Decision on Capital Increase by Subsidiary / 2025-02-18 Disclosures
[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Stoboclo & Osenvelt (CT-P41, Prolia & Xgeva Biosimilars) / 2025-02-18 Disclosures
[Disclosure] Celltrion (068270) – Approval of Part 1 & Part 2 Clinical Trial Application for Phase 3 Trial of CT-P55 (Cosentyx Biosimilar) in Europe / 2025-02-18 Disclosures
![[Disclosure] Samsung Electronics (005930) – Submission of Audit Report / 2025-02-18](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성전자.jpg)
![[Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
![[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Stoboclo & Osenvelt (CT-P41, Prolia & Xgeva Biosimilars) / 2025-02-18](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
![[Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2025-02-17](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환원익IPS.jpg)